Effect of different doses of pregabalin on skeletal muscle ischaemia-reperfusion injury in rats

The effect of pregabalin on tourniquet-induced ischemia-reperfusion injury: a prospective randomized study

Background/aim

The aim of this study was to investigate the efficacy of pregabalin on ischemia-reperfusion injuries.

Materials and methods

Fifty-four patients were randomly assigned into 2 groups. A 150-mg tablet of pregabalin was given the night before and then 1 h before the operation for patients in Group P (pregabalin group, n = 27). A placebo was given to patients in Group C (control group, n = 27) at the same times. After combined spinal-epidural anesthesia was performed, venous blood samples were taken before tourniquet inflation (t₁), just before tourniquet deflation (t₂), and 20 min after tourniquet deflation (t₃) for the analysis of total antioxidant status (TAS), total oxidant status (TOS), catalase (CAT), and ischemia-modified albumin (IMA).

Results

There was no significant difference in TAS levels between the groups for the t₃ period. However, the TAS in Group P was significantly higher in the t₃ period than the t₂ period (mean ± SD, 0.46 ± 0.1 vs. 0.38 ± 0.2 mmol of Trolox equivalent/L, respectively; P < 0.05). The CAT level in the t₃ period was significantly higher in Group P than Group C (mean ± SD, 53.04 ± 32.1 vs. 35.46 ± 17.2 µmol/formaldehyde, respectively; P < 0.05). In the t₃ period, the TOS was significantly lower in Group P than Group C (mean ± SD, 11.97 ± 5 vs. 18.29 ± 9.9 pg/mL, respectively; P < 0.05). The TOS in Group P was significantly lower in the t₃ period than the t₂ period (mean ± SD, 11.97 ± 5 vs. 18.98 ± 10.7 pg/mL, respectively; P < 0.0001).

Conclusion

Pregabalin has no marked antioxidant activity, but it contributes to the antioxidant defense system of an organism.